Looks like production has halted because of FDA concerns about the manufacturing facility (same situation with Interceptor last year or the year before):
Sequent Aims to Lure Buyers in $30 Billion Veterinary Market - Bloomberg Business
From the Bloomberg article:
Quote:
|
The FDA last year raised concerns about quality systems at Virbac SA’s manufacturing site in St. Louis, Missouri and the company halted production at the site. While some production has resumed, a number of important products will only return to the market in the second half of the year and the U.S. unit will see a “significant drop” in revenue this year, the company said last month.
|
Looks like another company is trying to gain a foothold in the industry with manufacturing plants in Turkey and India.